A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia
Status:
Terminated
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess changes in physical function in elderly patients (>=
65 years of age) with chronic anemia (Hb <= 11.0 g/dL) due to anemia of unknown cause and
receiving weekly subcutaneous doses of Epoetin alfa (PROCRIT®) versus placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.